Viewing nowClorak Tablet (Acyclovir)
Acyclovir 200mg
Tablet · Prescription medication
CTC Bio Co., Ltd.

MFDS item code 201803418 · Approved 2018.08.21 · Insurance code 669502370
Treatment and prevention of herpes simplex; treatment of chickenpox and shingles in children
This medicine is used to treat and prevent infections caused by the herpes simplex virus in skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in treating shingles virus infections and particularly helps relieve acute pain. It is used for the treatment of chickenpox and is suitable for children over 2 years old. However, the efficacy against postherpetic neuralgia has not yet been clearly demonstrated. Overall, this drug is used to improve symptoms through the treatment of various viral infections.
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg five times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is preferable to start treatment as soon as possible after infection; in recurrent cases, treatment should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer this medicine at 200 mg four times daily, approximately 6 hours apart. Alternatively, it may be administered at 400 mg twice daily, 12 hours apart. 2) The dose may subsequently be reduced to 200 mg two or three times daily after confirming its efficacy. 3) To assess the natural course of the disease, treatment should be periodically discontinued in patients receiving long-term treatment every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer this medicine at 200 mg four times daily, approximately 6 hours apart. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer this medicine at 800 mg five times daily, at approximately 4-hour intervals except during sleep, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is preferable to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance below 10 mL per minute), it is preferable to administer this medicine at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance below 10 mL per minute, it is preferable to reduce the dose to 800 mg twice daily, approximately 12 hours apart. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg three times daily, approximately 8 hours apart.
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — 2 years and older: Use the adult dose. 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — Under 2 years: Use 1/2 of the adult dose. 2. Treatment of chickenpox in children 2 years and older: Administer this medicine at 20 mg per kg of body weight per dose (maximum 800 mg per dose) four times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.
This medication should not be used by patients who have had allergic reactions to this drug or its ingredients, or to valacyclovir. Additionally, this medication contains lactose, so it should not be administered to patients with galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Patients with poor kidney function should be cautious when using this medication as it may cause adverse reactions in the central nervous system. Patients with liver dysfunction should also be careful as there is a risk of worsening liver function when using this medication. Infants, children, and elderly patients should be particularly cautious when using this medication, and dosage and intervals should be adjusted appropriately. During treatment with this medication, severe allergic reactions such as anaphylaxis shock may rarely occur, so if symptoms such as difficulty breathing, decreased blood pressure, or chest tightness appear, treatment should be stopped immediately and medical help should be sought. Hypersensitivity reactions such as skin rash, fever, blisters, or urticaria may occur, so if such symptoms arise, discontinue use and consult a doctor. Rarely, various neurological symptoms such as hair loss, severe skin conditions, altered consciousness, confusion, seizures, drowsiness, tremors, and dizziness may occur, particularly more frequently in elderly patients or those with kidney disease. Multiple side effects have been reported such as decreased kidney function, blood disorders, liver function anomalies, gastrointestinal disturbances, muscle pain, arrhythmia, and urination problems, so any abnormal symptoms should be reported to a healthcare provider immediately. This medication is most effective when administered as soon as symptoms appear for herpes simplex and chickenpox, and for shingles, it should be started within 5 days after the appearance of skin symptoms and chickenpox within 3 days. Immunocompromised patients may consider intravenous treatment. During treatment with this medication, it is important to maintain adequate hydration to reduce the risk of dehydration and kidney toxicity. Patients with recurrent genital herpes should discuss with their physician whether to continue using this medication after one year of treatment. This medication may cause drowsiness or altered consciousness, so caution should be exercised when driving or operating hazardous machinery, especially for those with compromised kidney function. There may be interactions when used with other drugs, so caution is especially needed when used in conjunction with probenecid, cimetidine, theophylline, or mycophenolate mofetil. Women who are pregnant or may become pregnant should be cautious when using this medication, and nursing mothers should discontinue breastfeeding as this medication may pass into breast milk. In infants and children, it should be administered carefully in the minimum effective dose only when necessary, as safety in neonates and low-birth-weight infants has not been established. Elderly patients may have increased blood concentrations of this medicine due to reduced kidney function, so dosage and intervals should be adjusted, and adequate hydration is necessary. In cases of overdose, serious symptoms such as agitation, coma, seizures, and somnolence may occur, and it can cause kidney damage, requiring immediate medical observation and appropriate treatment. Blood dialysis may be required to control blood concentration.
Not everyone experiences these, and they can vary from person to person.
Keep this medication in a tightly closed container to prevent air and moisture from entering. It is best stored in a cool and dry place below 25 degrees Celsius.
Light blue round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAcyclovir 200mg
Tablet · Prescription medication
CTC Bio Co., Ltd.

Acyclovir 200mg
Tablet · Prescription medication
Kyung dong Pharm Co., Ltd.

Acyclovir 200mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.
Acyclovir
Prescription medication
Baskan Biopharmaceutical Co., Ltd.
Acyclovir 50mg
Cream · OTC medication
Dongkwang Pharmaceutical Co., Ltd.

Acyclovir 400mg
Tablet · Prescription medication
Kyung dong Pharm Co., Ltd.
Acyclovir 50mg
Cream · OTC medication
Kyungdong Pharmaceutical Co., Ltd.

Acyclovir 200mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.